Danushka Seneviratne to Imatinib Mesylate
This is a "connection" page, showing publications Danushka Seneviratne has written about Imatinib Mesylate.
Connection Strength
0.027
-
The DREAM complex mediates GIST cell quiescence and is a novel therapeutic target to enhance imatinib-induced apoptosis. Cancer Res. 2013 Aug 15; 73(16):5120-9.
Score: 0.027
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.